CEVA Logistics AG

  • ISIN: CH0413237394
  • Land: Schweiz

Nachricht vom 17.05.2018 | 07:00

CEVA Logistics AG: CEVA Logistics' credit rating upgraded by Moody's by four notches to B1

CEVA Logistics AG / Key word(s): Rating

17-May-2018 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


 

CEVA Logistics' credit rating upgraded by Moody's by four notches to B1

Baar, Switzerland, 16 May 2018 -- CEVA Logistics AG ("CEVA") announces that Moody's Investors Service ("Moody's") has today upgraded the Group's Corporate Family Rating to B1 following the successful IPO on SIX Swiss Exchange on 4 May 2018. The upgrade by four notches reflects the improved financial position and free cash flow generation as a result of the IPO as well as the ongoing improvements in operating performance. Moody's has also upgraded the instrument ratings on the existing debt facilities.

As previously announced, CEVA has started the repayment of some of its indebtedness and plans to replace the majority of its remaining debt facilities through a comprehensive refinancing in coming months.

-ENDS-

For more information, please contact:

Investors:
Pierre Benaich
SVP Investor Relations
pierre.benaich@cevalogistics.com
+41 41 547 0048

Media:
David Urbach
SVP Corporate Development
david.urbach@cevalogistics.com
+41 799 333 083

CEVA - Making business flow
CEVA Logistics, a leading global asset-light supply chain management company, designs and implements industry leading solutions for large and medium-size national and multinational companies. Approximately 56,000 employees in more than 160 countries are dedicated to delivering effective and robust supply-chain solutions across a variety of sectors where CEVA applies its operational expertise to provide best-in-class services across its integrated network. For more information, please visit www.cevalogistics.com.

 



End of ad hoc announcement

show this

GBC im Fokus

M1 Kliniken: Geschäftsjahr über den Erwartungen

Mit dem deutlichen Anstieg auf 21 Klinikstandorte (Ende 2016: 13) hat die auf ästhetische Medizin spezialisierte M1 Kliniken AG die Basis für einen Ausbau der Umsatz- und Ertragsbasis gelegt. Hinzu kommt die bereits in Umsetzung befindliche Erschließung weiterer Umsatzströme, wie etwa die Erweiterung der Eigenmarken oder die Abdeckung der ästhetischen Zahnmedizin. Das Kursziel beläuft sich auf 18,50 € und das Rating lautet KAUFEN.

Aktueller Webcast

EQS Group AG

Q3-report 2018

18. Mai 2018

Aktuelle Research-Studie

Energiekontor AG

Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy

18. Mai 2018